Anavasi Diagnostics® (Biotechnology, Manufacturing) — Funding, Investors & Signals 2026

Anavasi Diagnostics®

Rapidly detecting the presence of RNA with breakthrough molecular technology.

Founded 2020

Redmond, United States 26 employees Convertible Note Biotechnology, Manufacturing +1

Anavasi Diagnostics® is a biotechnology company founded in 2020, based in the United States. The company's slogan "Rapidly detecting the presence of RNA with breakthrough molecular technology" encapsulates its mission. Anavasi Diagnostics® focuses on developing rapid, precise, and inexpensive diagnostic tests to address the global challenge of detecting COVID-19 infection. The company's flagship product, The AscencioDx® Covid-19 Test and The AscencioDx® Molecular Detector, aims to provide a precise diagnosis of COVID-19 in under 30 minutes, a significant improvement from the 1-3 days required for PCR testing. Utilizing patent-pending proprietary technologies, the diagnostic test is designed to be painless and quick, administering a lower-nasal swab in just seconds. Anavasi Diagnostics® underscores its commitment to ongoing development and marketing of diagnostic test systems for diseases beyond COVID-19, using its PCR-equivalent point-of-care diagnostic platform to eliminate delays, reduce costs, and enhance precision in testing. It's worth noting that while The AscencioDx® Covid-19 Test and The AscencioDx® Molecular Detector have not been FDA cleared or approved, they have been authorized for emergency use by the FDA under an EUA for use by authorized laboratories, specifically for the detection of nucleic acid from SARS-CoV-2. Anavasi Diagnostics® presents a compelling opportunity for investors, with its disruptive approach to rapid diagnostics amidst the ongoing pandemic and the potential for expanding its platform to address a broader range of diseases.

FAQ About Anavasi Diagnostics®

Rapidly detecting the presence of RNA with breakthrough molecular technology.

Anavasi Diagnostics® was founded in 2020.

Anavasi Diagnostics® is headquartered in Redmond, United States.

Anavasi Diagnostics® operates in the following industries: Biotechnology, Manufacturing, Medical Devices.

Anavasi Diagnostics® has approximately 26 employees.

Top alternatives and competitors to Anavasi Diagnostics® include Directcare, Applied BioCode, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Anavasi Diagnostics® and Directcare are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Anavasi Diagnostics®

General Information

Track Anavasi Diagnostics®

Discover More

About Anavasi Diagnostics®

Anavasi Diagnostics® Alternatives & Competitors

FAQ About Anavasi Diagnostics®

Don't just browse. Track.